Healthcare Stocks Top News Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and… Ryan AllwayJune 16, 2023